• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol].

作者信息

Rüffer C, Zorn G, Henkel E, Mitzkat H J

出版信息

Arzneimittelforschung. 1982;32(9):1149-52.

PMID:6890841
Abstract
  1. When giving 100 mg allopurinol and 20 mg benzbromarone in a fixed combination we found that the oxipurinol levels differed at 0 and after 4 h from those after administration of 100 mg allopurinol; the oxipurinol clearance is increased; benzbromarone increased the glomerular filtration rate as well as the urine volume. 2. The urate serum levels are decreased under additional administration of benzbromarone, the urate clearance is increased; urate levels in serum dropped slower than under monotherapy with alloprinol and increased again within the last 12 h.
摘要

相似文献

1
[Influence of benzbromarone on the pharmacokinetics and pharmacodynamics of oxipurinol].
Arzneimittelforschung. 1982;32(9):1149-52.
2
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.长期口服给药后别嘌醇和氧嘌呤醇的动力学。与苯溴马隆的相互作用。
Eur J Clin Pharmacol. 1986;31(1):53-8. doi: 10.1007/BF00870986.
3
[Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].[在递增剂量的别嘌醇与苯溴马隆联合治疗中别嘌醇、氧嘌呤醇和氧嘌呤类的排泄及血清浓度]
Med Welt. 1983 Sep 9;34(36):974-9.
4
Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.
Eur J Clin Pharmacol. 1982;22(1):77-84. doi: 10.1007/BF00606429.
5
Does benzbromarone in therapeutic doses raise renal excretion of oxipurinol?治疗剂量的苯溴马隆是否会提高氧嘌呤醇的肾脏排泄量?
Klin Wochenschr. 1984 Dec 17;62(24):1170-2. doi: 10.1007/BF01712184.
6
[Clinical pharmacokinetics of allopurinol. 3. Allopurinol/oxipurinol pharmacokinetics following administration of a controlled release allopurinol preparation].
Arzneimittelforschung. 1986 Jun;36(6):988-93.
7
[The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability].
Arzneimittelforschung. 1985;35(4):760-5.
8
The effect of dietary protein on the clearance of allopurinol and oxypurinol.膳食蛋白质对别嘌醇和氧嘌呤醇清除率的影响。
N Engl J Med. 1985 Sep 26;313(13):771-6. doi: 10.1056/NEJM198509263131302.
9
The pharmacology of hypouricemic effect of benzbromarone.苯溴马隆降尿酸作用的药理学
J Rheumatol. 1975 Dec;2(4):437-45.
10
[The clinical pharmacokinetics of allopurinol. 2. Allopurinol/oxypurinol pharmacokinetics following allopurinol in single doses and multiple application].
Arzneimittelforschung. 1985;35(7):1093-6.

引用本文的文献

1
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients?苯溴马隆治疗痛风的获益-风险评估。其退市符合患者的最大利益吗?
Drug Saf. 2008;31(8):643-65. doi: 10.2165/00002018-200831080-00002.
2
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.别嘌醇与丙磺舒在健康受试者中的药代动力学和药效学相互作用。
Clin Pharmacokinet. 2008;47(2):111-8. doi: 10.2165/00003088-200847020-00004.
3
Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.
别嘌醇和氧嘌呤醇的临床药代动力学与药效学
Clin Pharmacokinet. 2007;46(8):623-44. doi: 10.2165/00003088-200746080-00001.
4
Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.长期口服给药后别嘌醇和氧嘌呤醇的动力学。与苯溴马隆的相互作用。
Eur J Clin Pharmacol. 1986;31(1):53-8. doi: 10.1007/BF00870986.
5
[Differential indications for uricosuric drugs and allopurinol].
Klin Wochenschr. 1989 Mar 1;67(5):313-5. doi: 10.1007/BF01892902.